Literature DB >> 9557297

Homotypic and heterotypic IgG and IgM antibody responses in adults infected with small round structured viruses.

A D Hale1, D C Lewis, X Jiang, D W Brown.   

Abstract

Antibody responses to recombinant Norwalk (rNV) and Mexico (rMXV) viral capsid proteins were studied in 39 adults involved in outbreaks of gastroenteritis associated with genogroup 2 small round structured viruses (SRSVs). Nineteen individuals were involved in outbreaks associated with MXV-like strains and 20 in outbreaks associated with four other genogroup 2 SRSVs. IgG antibodies were measured in acute and convalescent sera using indirect enzyme-linked immunosorbent assay (ELISA), and IgM was measured by indirect and capture ELISAs. Nineteen (49%) patients demonstrated a significant rise in IgG to rMXV with four (10%) patients also showing anamnestic responses to rNV. Fourteen patients were positive in the rMXV IgM-capture ELISA, representing 74% of patients demonstrating IgG rises. IgG and IgM responses to rMXV were observed in both groups, although higher levels of responses were seen in adults infected with MXV-like strains than those infected with non-MXV genogroup 2 viruses. No significant IgM responses were observed to rNV. These results indicate that, following SRSV infection, adults show a rise in antibody which is broadly reactive to viruses within but not between genogroups, although greater homotypic than heterotypic responses are produced. These findings have implications for interpretation of seroepidemiological studies and serodiagnosis of SRSV infections using recombinant capsids.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9557297

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  12 in total

1.  Molecular cloning, expression, and antigenicity of Seto virus belonging to genogroup I Norwalk-like viruses.

Authors:  S Kobayashi; K Sakae; Y Suzuki; K Shinozaki; M Okada; H Ishiko; K Kamata; K Suzuki; K Natori; T Miyamura; N Takeda
Journal:  J Clin Microbiol       Date:  2000-09       Impact factor: 5.948

2.  Expression and self-assembly of Grimsby virus: antigenic distinction from Norwalk and Mexico viruses.

Authors:  A D Hale; S E Crawford; M Ciarlet; J Green; C Gallimore; D W Brown; X Jiang; M K Estes
Journal:  Clin Diagn Lab Immunol       Date:  1999-01

3.  Binding of Norwalk virus-like particles to ABH histo-blood group antigens is blocked by antisera from infected human volunteers or experimentally vaccinated mice.

Authors:  Patrick R Harrington; Lisa Lindesmith; Boyd Yount; Christine L Moe; Ralph S Baric
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

4.  Identification of cross-reactive norovirus CD4+ T cell epitopes.

Authors:  Anna D LoBue; Lisa C Lindesmith; Ralph S Baric
Journal:  J Virol       Date:  2010-06-23       Impact factor: 5.103

5.  Characterization of capsid genes, expressed in the baculovirus system, of three new genetically distinct strains of "Norwalk-like viruses".

Authors:  G Belliot; J S Noel; J F Li; Y Seto; C D Humphrey; T Ando; R I Glass; S S Monroe
Journal:  J Clin Microbiol       Date:  2001-12       Impact factor: 5.948

6.  Immunoglobulin M antibody test to detect genogroup II Norwalk-like virus infection.

Authors:  J P Brinker; N R Blacklow; X Jiang; M K Estes; C L Moe; J E Herrmann
Journal:  J Clin Microbiol       Date:  1999-09       Impact factor: 5.948

7.  Norovirus GII.4 strain antigenic variation.

Authors:  Lisa C Lindesmith; Eric F Donaldson; Ralph S Baric
Journal:  J Virol       Date:  2010-10-27       Impact factor: 5.103

Review 8.  Diagnosis of noncultivatable gastroenteritis viruses, the human caliciviruses.

Authors:  R L Atmar; M K Estes
Journal:  Clin Microbiol Rev       Date:  2001-01       Impact factor: 26.132

9.  Alphavirus-adjuvanted norovirus-like particle vaccines: heterologous, humoral, and mucosal immune responses protect against murine norovirus challenge.

Authors:  Anna D LoBue; Joseph M Thompson; Lisa Lindesmith; Robert E Johnston; Ralph S Baric
Journal:  J Virol       Date:  2009-01-28       Impact factor: 5.103

10.  A single-amino-acid substitution in the P2 domain of VP1 of murine norovirus is sufficient for escape from antibody neutralization.

Authors:  Vance P Lochridge; Michele E Hardy
Journal:  J Virol       Date:  2007-09-05       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.